(Q54602584)

1 June 2018

title

Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P. (English)

1 reference

1 June 2018

author name string

Hsien-Hsiung Lee

1

1 reference

1 June 2018

Fuu-Jen Tsai

2

1 reference

1 June 2018

Yann-Jinn Lee

3

1 reference

1 June 2018

Yuh-Cheng Yang

4

1 reference

1 June 2018

publication date

8 May 2006

1 reference

1 June 2018

Molecular Genetics and Metabolism

published in

1 reference

1 June 2018

volume

88

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

372-377

1 reference

1 June 2018

Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease as

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

CYP21 mutations and congenital adrenal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Congenital adrenal hyperplasia. (1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

The molecular genetics of 21-hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Use of PCR-based amplification analysis as a substitute for the southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Characterization of frequent deletions causing steroid 21-hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Mutation of IVS2 -12A/C>G in combination with 707-714delGAGACTAC in the CYP21 gene is caused by deletion of the C4-CYP21 repeat module with steroid 21-hydroxylase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Difference in transcriptional activity of two homologous CYP21A genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

Diversity of the CYP21P-like gene in CYP21 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.013

10.1016/J.YMGME.2006.03.013

7 January 2021

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018